 | • レポートコード：MRC2Q12-18513 • 出版社/出版日：QYResearch / 2022年12月 • レポート形態：英文、PDF、113ページ • 納品方法：Eメール（納期：3営業日） • 産業分類：医療機器＆消耗品 |
| Single User | ￥735,000 (USD4,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,470,000 (USD9,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 新型コロナウイルス感染症とロシア・ウクライナ戦争の影響により、豚パルボウイルス病ワクチンのグローバル市場は 2022にxxxドルと推定され、2028年までにxxxドルの規模に達し、2022年から2028年の予測期間中にxxx%のCAGRで成長すると予測されています。 豚パルボウイルス病ワクチンのアメリカ市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 豚パルボウイルス病ワクチンの中国市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 豚パルボウイルス病ワクチンのヨーロッパ市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 生産面において、本レポートは2017年から2022年までの豚パルボウイルス病ワクチンの生産、成長率、メーカー別市場シェア、地域別市場シェア、および2028年までの予測を調査しています。販売面において、本レポートは2017年から2022年までの地域別、企業別、タイプ別、アプリケーション別の豚パルボウイルス病ワクチンの売上および2028年までの予測に焦点を当てています。 豚パルボウイルス病ワクチンのグローバル主要企業には、Merck Animal Health、HIPRA、Zoetis、Ceva、Bioveta、Boehringer Ingelheim、Harbin Pharmaceutical Group、Wuhan Keqian Biology、DHN、China Animal Husbandy Industry、Qilu Animal Health Products Factorys、Shandong HuaHong Biological Engineering、Shanghai Hile Biological、Liaoning Yikang Biological、Jilin Zhengye Biological Productなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。 豚パルボウイルス病ワクチン市場は、タイプとアプリケーションによって区分されます。世界の豚パルボウイルス病ワクチン市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別およびアプリケーション別の販売量、売上、予測に焦点を当てています。 【タイプ別セグメント】 <107.0TCID50/mL、≧107.0TCID50/mL 【アプリケーション別セグメント】 雌豚、猪 【掲載地域】 北米：アメリカ、カナダ ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア 中南米：メキシコ、ブラジル、アルゼンチン 中東・アフリカ：トルコ、サウジアラビア、UAE 【目次（一部）】 ・調査の範囲 - 豚パルボウイルス病ワクチン製品概要 - タイプ別市場（<107.0TCID50/mL、≧107.0TCID50/mL） - アプリケーション別市場（雌豚、猪） - 調査の目的 ・エグゼクティブサマリー - 世界の豚パルボウイルス病ワクチン販売量予測2017-2028 - 世界の豚パルボウイルス病ワクチン売上予測2017-2028 - 豚パルボウイルス病ワクチンの地域別販売量 - 豚パルボウイルス病ワクチンの地域別売上 - 北米市場 - ヨーロッパ市場 - アジア太平洋市場 - 中南米市場 - 中東・アフリカ市場 ・メーカーの競争状況 - 主要メーカー別豚パルボウイルス病ワクチン販売量 - 主要メーカー別豚パルボウイルス病ワクチン売上 - 主要メーカー別豚パルボウイルス病ワクチン価格 - 競争状況の分析 - 企業M&A動向 ・タイプ別市場規模（<107.0TCID50/mL、≧107.0TCID50/mL） - 豚パルボウイルス病ワクチンのタイプ別販売量 - 豚パルボウイルス病ワクチンのタイプ別売上 - 豚パルボウイルス病ワクチンのタイプ別価格 ・アプリケーション別市場規模（雌豚、猪） - 豚パルボウイルス病ワクチンのアプリケーション別販売量 - 豚パルボウイルス病ワクチンのアプリケーション別売上 - 豚パルボウイルス病ワクチンのアプリケーション別価格 ・北米市場 - 北米の豚パルボウイルス病ワクチン市場規模（タイプ別、アプリケーション別） - 主要国別の豚パルボウイルス病ワクチン市場規模（アメリカ、カナダ） ・ヨーロッパ市場 - ヨーロッパの豚パルボウイルス病ワクチン市場規模（タイプ別、アプリケーション別） - 主要国別の豚パルボウイルス病ワクチン市場規模（ドイツ、フランス、イギリス、イタリア、ロシア） ・アジア太平洋市場 - アジア太平洋の豚パルボウイルス病ワクチン市場規模（タイプ別、アプリケーション別） - 主要国別の豚パルボウイルス病ワクチン市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア） ・中南米市場 - 中南米の豚パルボウイルス病ワクチン市場規模（タイプ別、アプリケーション別） - 主要国別の豚パルボウイルス病ワクチン市場規模（メキシコ、ブラジル、アルゼンチン） ・中東・アフリカ市場 - 中東・アフリカの豚パルボウイルス病ワクチン市場規模（タイプ別、アプリケーション別） - 主要国別の豚パルボウイルス病ワクチン市場規模（トルコ、サウジアラビア） ・企業情報 Merck Animal Health、HIPRA、Zoetis、Ceva、Bioveta、Boehringer Ingelheim、Harbin Pharmaceutical Group、Wuhan Keqian Biology、DHN、China Animal Husbandy Industry、Qilu Animal Health Products Factorys、Shandong HuaHong Biological Engineering、Shanghai Hile Biological、Liaoning Yikang Biological、Jilin Zhengye Biological Product ・産業チェーン及び販売チャネル分析 - 豚パルボウイルス病ワクチンの産業チェーン分析 - 豚パルボウイルス病ワクチンの原材料 - 豚パルボウイルス病ワクチンの生産プロセス - 豚パルボウイルス病ワクチンの販売及びマーケティング - 豚パルボウイルス病ワクチンの主要顧客 ・マーケットドライバー、機会、課題、リスク要因分析 - 豚パルボウイルス病ワクチンの産業動向 - 豚パルボウイルス病ワクチンのマーケットドライバー - 豚パルボウイルス病ワクチンの課題 - 豚パルボウイルス病ワクチンの阻害要因 ・主な調査結果 |
Report Overview
Due to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for Product Name estimated at US$ million in the year 2022, is projected to reach a revised size of US$ million by 2028, growing at a CAGR of % during the forecast period 2022-2028.
The USA market for Swine Parvovirus Disease Vaccine is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The China market for Swine Parvovirus Disease Vaccine is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The Europe market for Swine Parvovirus Disease Vaccine is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The global key manufacturers of Swine Parvovirus Disease Vaccine include Merck Animal Health, HIPRA, Zoetis, Ceva, Bioveta, Boehringer Ingelheim, Harbin Pharmaceutical Group, Wuhan Keqian Biology and DHN, etc. In 2021, the global top five players had a share approximately % in terms of revenue.
Report Scope
This latest report researches the industry structure, sales, revenue, price and gross margin. Major producers’ production locations, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Swine Parvovirus Disease Vaccine manufacturers, distributors, end users, industry associations, governments’ industry bureaus, industry publications, industry experts, third party database, and our in-house databases.
This report also includes a discussion of the major players across each regional Swine Parvovirus Disease Vaccine market. Further, it explains the major drivers and regional dynamics of the global Swine Parvovirus Disease Vaccine market and current trends within the industry.
Key Companies Covered
In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and market share analysis of the prominent players are also provided in this section. Additionally, the specialists have done an all-encompassing analysis of each player. They have also provided reliable sales, revenue, price, market share and rank data of the manufacturers for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report:
Merck Animal Health
HIPRA
Zoetis
Ceva
Bioveta
Boehringer Ingelheim
Harbin Pharmaceutical Group
Wuhan Keqian Biology
DHN
China Animal Husbandy Industry
Qilu Animal Health Products Factorys
Shandong HuaHong Biological Engineering
Shanghai Hile Biological
Liaoning Yikang Biological
Jilin Zhengye Biological Product
Market Segments
This report has explored the key segments: by Type and by Application. The lucrativeness and growth potential have been looked into by the industry experts in this report. This report also provides sales, revenue and average price forecast data by type and by application segments based on sales, price, and value for the period 2017-2028.
Swine Parvovirus Disease Vaccine Segment by Type
<107.0 TCID50/mL
≥107.0 TCID50/mL
Swine Parvovirus Disease Vaccine Segment by Application
Sows
Boars
Key Regions & Countries
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the value and sales data of each region and country for the period 2017-2028.
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Swine Parvovirus Disease Vaccine market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Report Includes:
This report presents an overview of global market for Swine Parvovirus Disease Vaccine, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2017 - 2021, estimates for 2022, and projections of CAGR through 2028.
This report researches the key producers of Swine Parvovirus Disease Vaccine, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Swine Parvovirus Disease Vaccine, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Swine Parvovirus Disease Vaccine sales, revenue, market share and industry ranking of main manufacturers, data from 2017 to 2022. Identification of the major stakeholders in the global Swine Parvovirus Disease Vaccine market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, sales, revenue, and price, from 2017 to 2028. Evaluation and forecast the market size for Swine Parvovirus Disease Vaccine sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Merck Animal Health, HIPRA, Zoetis, Ceva, Bioveta, Boehringer Ingelheim, Harbin Pharmaceutical Group, Wuhan Keqian Biology and DHN, etc.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Swine Parvovirus Disease Vaccine in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Swine Parvovirus Disease Vaccine manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments according to product types, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments according to application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America by type, by application and by country, sales and revenue for each segment.
Chapter 7: Europe by type, by application and by country, sales and revenue for each segment.
Chapter 8: Asia Pacific by type, by application and by country, sales and revenue for each segment.
Chapter 9: Latin America by type, by application and by country, sales and revenue for each segment.
Chapter 10: Middle East and Africa by type, by application and by country, sales and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Swine Parvovirus Disease Vaccine sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.
1 Study Coverage
1.1 Swine Parvovirus Disease Vaccine Product Introduction
1.2 Market by Type
1.2.1 Global Swine Parvovirus Disease Vaccine Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 <107.0 TCID50/mL
1.2.3 ≥107.0 TCID50/mL
1.3 Market by Application
1.3.1 Global Swine Parvovirus Disease Vaccine Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Sows
1.3.3 Boars
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Swine Parvovirus Disease Vaccine Sales Estimates and Forecasts 2017-2028
2.2 Global Swine Parvovirus Disease Vaccine Revenue Estimates and Forecasts 2017-2028
2.3 Global Swine Parvovirus Disease Vaccine Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Swine Parvovirus Disease Vaccine Sales by Region
2.4.1 Global Swine Parvovirus Disease Vaccine Sales by Region (2017-2022)
2.4.2 Global Sales Swine Parvovirus Disease Vaccine by Region (2023-2028)
2.5 Global Swine Parvovirus Disease Vaccine Revenue by Region
2.5.1 Global Swine Parvovirus Disease Vaccine Revenue by Region (2017-2022)
2.5.2 Global Swine Parvovirus Disease Vaccine Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Swine Parvovirus Disease Vaccine Sales by Manufacturers
3.1.1 Global Top Swine Parvovirus Disease Vaccine Manufacturers by Sales (2017-2022)
3.1.2 Global Swine Parvovirus Disease Vaccine Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Swine Parvovirus Disease Vaccine in 2021
3.2 Global Swine Parvovirus Disease Vaccine Revenue by Manufacturers
3.2.1 Global Swine Parvovirus Disease Vaccine Revenue by Manufacturers (2017-2022)
3.2.2 Global Swine Parvovirus Disease Vaccine Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Swine Parvovirus Disease Vaccine Revenue in 2021
3.3 Global Swine Parvovirus Disease Vaccine Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Swine Parvovirus Disease Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Swine Parvovirus Disease Vaccine Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Swine Parvovirus Disease Vaccine Sales by Type
4.1.1 Global Swine Parvovirus Disease Vaccine Historical Sales by Type (2017-2022)
4.1.2 Global Swine Parvovirus Disease Vaccine Forecasted Sales by Type (2023-2028)
4.1.3 Global Swine Parvovirus Disease Vaccine Sales Market Share by Type (2017-2028)
4.2 Global Swine Parvovirus Disease Vaccine Revenue by Type
4.2.1 Global Swine Parvovirus Disease Vaccine Historical Revenue by Type (2017-2022)
4.2.2 Global Swine Parvovirus Disease Vaccine Forecasted Revenue by Type (2023-2028)
4.2.3 Global Swine Parvovirus Disease Vaccine Revenue Market Share by Type (2017-2028)
4.3 Global Swine Parvovirus Disease Vaccine Price by Type
4.3.1 Global Swine Parvovirus Disease Vaccine Price by Type (2017-2022)
4.3.2 Global Swine Parvovirus Disease Vaccine Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Swine Parvovirus Disease Vaccine Sales by Application
5.1.1 Global Swine Parvovirus Disease Vaccine Historical Sales by Application (2017-2022)
5.1.2 Global Swine Parvovirus Disease Vaccine Forecasted Sales by Application (2023-2028)
5.1.3 Global Swine Parvovirus Disease Vaccine Sales Market Share by Application (2017-2028)
5.2 Global Swine Parvovirus Disease Vaccine Revenue by Application
5.2.1 Global Swine Parvovirus Disease Vaccine Historical Revenue by Application (2017-2022)
5.2.2 Global Swine Parvovirus Disease Vaccine Forecasted Revenue by Application (2023-2028)
5.2.3 Global Swine Parvovirus Disease Vaccine Revenue Market Share by Application (2017-2028)
5.3 Global Swine Parvovirus Disease Vaccine Price by Application
5.3.1 Global Swine Parvovirus Disease Vaccine Price by Application (2017-2022)
5.3.2 Global Swine Parvovirus Disease Vaccine Price Forecast by Application (2023-2028)
6 North America
6.1 North America Swine Parvovirus Disease Vaccine Market Size by Type
6.1.1 North America Swine Parvovirus Disease Vaccine Sales by Type (2017-2028)
6.1.2 North America Swine Parvovirus Disease Vaccine Revenue by Type (2017-2028)
6.2 North America Swine Parvovirus Disease Vaccine Market Size by Application
6.2.1 North America Swine Parvovirus Disease Vaccine Sales by Application (2017-2028)
6.2.2 North America Swine Parvovirus Disease Vaccine Revenue by Application (2017-2028)
6.3 North America Swine Parvovirus Disease Vaccine Market Size by Country
6.3.1 North America Swine Parvovirus Disease Vaccine Sales by Country (2017-2028)
6.3.2 North America Swine Parvovirus Disease Vaccine Revenue by Country (2017-2028)
6.3.3 United States
6.3.4 Canada
7 Europe
7.1 Europe Swine Parvovirus Disease Vaccine Market Size by Type
7.1.1 Europe Swine Parvovirus Disease Vaccine Sales by Type (2017-2028)
7.1.2 Europe Swine Parvovirus Disease Vaccine Revenue by Type (2017-2028)
7.2 Europe Swine Parvovirus Disease Vaccine Market Size by Application
7.2.1 Europe Swine Parvovirus Disease Vaccine Sales by Application (2017-2028)
7.2.2 Europe Swine Parvovirus Disease Vaccine Revenue by Application (2017-2028)
7.3 Europe Swine Parvovirus Disease Vaccine Market Size by Country
7.3.1 Europe Swine Parvovirus Disease Vaccine Sales by Country (2017-2028)
7.3.2 Europe Swine Parvovirus Disease Vaccine Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Swine Parvovirus Disease Vaccine Market Size by Type
8.1.1 Asia Pacific Swine Parvovirus Disease Vaccine Sales by Type (2017-2028)
8.1.2 Asia Pacific Swine Parvovirus Disease Vaccine Revenue by Type (2017-2028)
8.2 Asia Pacific Swine Parvovirus Disease Vaccine Market Size by Application
8.2.1 Asia Pacific Swine Parvovirus Disease Vaccine Sales by Application (2017-2028)
8.2.2 Asia Pacific Swine Parvovirus Disease Vaccine Revenue by Application (2017-2028)
8.3 Asia Pacific Swine Parvovirus Disease Vaccine Market Size by Region
8.3.1 Asia Pacific Swine Parvovirus Disease Vaccine Sales by Region (2017-2028)
8.3.2 Asia Pacific Swine Parvovirus Disease Vaccine Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Swine Parvovirus Disease Vaccine Market Size by Type
9.1.1 Latin America Swine Parvovirus Disease Vaccine Sales by Type (2017-2028)
9.1.2 Latin America Swine Parvovirus Disease Vaccine Revenue by Type (2017-2028)
9.2 Latin America Swine Parvovirus Disease Vaccine Market Size by Application
9.2.1 Latin America Swine Parvovirus Disease Vaccine Sales by Application (2017-2028)
9.2.2 Latin America Swine Parvovirus Disease Vaccine Revenue by Application (2017-2028)
9.3 Latin America Swine Parvovirus Disease Vaccine Market Size by Country
9.3.1 Latin America Swine Parvovirus Disease Vaccine Sales by Country (2017-2028)
9.3.2 Latin America Swine Parvovirus Disease Vaccine Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
9.3.6 Colombia
10 Middle East and Africa
10.1 Middle East and Africa Swine Parvovirus Disease Vaccine Market Size by Type
10.1.1 Middle East and Africa Swine Parvovirus Disease Vaccine Sales by Type (2017-2028)
10.1.2 Middle East and Africa Swine Parvovirus Disease Vaccine Revenue by Type (2017-2028)
10.2 Middle East and Africa Swine Parvovirus Disease Vaccine Market Size by Application
10.2.1 Middle East and Africa Swine Parvovirus Disease Vaccine Sales by Application (2017-2028)
10.2.2 Middle East and Africa Swine Parvovirus Disease Vaccine Revenue by Application (2017-2028)
10.3 Middle East and Africa Swine Parvovirus Disease Vaccine Market Size by Country
10.3.1 Middle East and Africa Swine Parvovirus Disease Vaccine Sales by Country (2017-2028)
10.3.2 Middle East and Africa Swine Parvovirus Disease Vaccine Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Merck Animal Health
11.1.1 Merck Animal Health Corporation Information
11.1.2 Merck Animal Health Overview
11.1.3 Merck Animal Health Swine Parvovirus Disease Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Merck Animal Health Swine Parvovirus Disease Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Merck Animal Health Recent Developments
11.2 HIPRA
11.2.1 HIPRA Corporation Information
11.2.2 HIPRA Overview
11.2.3 HIPRA Swine Parvovirus Disease Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 HIPRA Swine Parvovirus Disease Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 HIPRA Recent Developments
11.3 Zoetis
11.3.1 Zoetis Corporation Information
11.3.2 Zoetis Overview
11.3.3 Zoetis Swine Parvovirus Disease Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Zoetis Swine Parvovirus Disease Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Zoetis Recent Developments
11.4 Ceva
11.4.1 Ceva Corporation Information
11.4.2 Ceva Overview
11.4.3 Ceva Swine Parvovirus Disease Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Ceva Swine Parvovirus Disease Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Ceva Recent Developments
11.5 Bioveta
11.5.1 Bioveta Corporation Information
11.5.2 Bioveta Overview
11.5.3 Bioveta Swine Parvovirus Disease Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Bioveta Swine Parvovirus Disease Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Bioveta Recent Developments
11.6 Boehringer Ingelheim
11.6.1 Boehringer Ingelheim Corporation Information
11.6.2 Boehringer Ingelheim Overview
11.6.3 Boehringer Ingelheim Swine Parvovirus Disease Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Boehringer Ingelheim Swine Parvovirus Disease Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Boehringer Ingelheim Recent Developments
11.7 Harbin Pharmaceutical Group
11.7.1 Harbin Pharmaceutical Group Corporation Information
11.7.2 Harbin Pharmaceutical Group Overview
11.7.3 Harbin Pharmaceutical Group Swine Parvovirus Disease Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Harbin Pharmaceutical Group Swine Parvovirus Disease Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Harbin Pharmaceutical Group Recent Developments
11.8 Wuhan Keqian Biology
11.8.1 Wuhan Keqian Biology Corporation Information
11.8.2 Wuhan Keqian Biology Overview
11.8.3 Wuhan Keqian Biology Swine Parvovirus Disease Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Wuhan Keqian Biology Swine Parvovirus Disease Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Wuhan Keqian Biology Recent Developments
11.9 DHN
11.9.1 DHN Corporation Information
11.9.2 DHN Overview
11.9.3 DHN Swine Parvovirus Disease Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 DHN Swine Parvovirus Disease Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 DHN Recent Developments
11.10 China Animal Husbandy Industry
11.10.1 China Animal Husbandy Industry Corporation Information
11.10.2 China Animal Husbandy Industry Overview
11.10.3 China Animal Husbandy Industry Swine Parvovirus Disease Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 China Animal Husbandy Industry Swine Parvovirus Disease Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 China Animal Husbandy Industry Recent Developments
11.11 Qilu Animal Health Products Factorys
11.11.1 Qilu Animal Health Products Factorys Corporation Information
11.11.2 Qilu Animal Health Products Factorys Overview
11.11.3 Qilu Animal Health Products Factorys Swine Parvovirus Disease Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 Qilu Animal Health Products Factorys Swine Parvovirus Disease Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Qilu Animal Health Products Factorys Recent Developments
11.12 Shandong HuaHong Biological Engineering
11.12.1 Shandong HuaHong Biological Engineering Corporation Information
11.12.2 Shandong HuaHong Biological Engineering Overview
11.12.3 Shandong HuaHong Biological Engineering Swine Parvovirus Disease Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.12.4 Shandong HuaHong Biological Engineering Swine Parvovirus Disease Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Shandong HuaHong Biological Engineering Recent Developments
11.13 Shanghai Hile Biological
11.13.1 Shanghai Hile Biological Corporation Information
11.13.2 Shanghai Hile Biological Overview
11.13.3 Shanghai Hile Biological Swine Parvovirus Disease Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.13.4 Shanghai Hile Biological Swine Parvovirus Disease Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Shanghai Hile Biological Recent Developments
11.14 Liaoning Yikang Biological
11.14.1 Liaoning Yikang Biological Corporation Information
11.14.2 Liaoning Yikang Biological Overview
11.14.3 Liaoning Yikang Biological Swine Parvovirus Disease Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.14.4 Liaoning Yikang Biological Swine Parvovirus Disease Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 Liaoning Yikang Biological Recent Developments
11.15 Jilin Zhengye Biological Product
11.15.1 Jilin Zhengye Biological Product Corporation Information
11.15.2 Jilin Zhengye Biological Product Overview
11.15.3 Jilin Zhengye Biological Product Swine Parvovirus Disease Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.15.4 Jilin Zhengye Biological Product Swine Parvovirus Disease Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.15.5 Jilin Zhengye Biological Product Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Swine Parvovirus Disease Vaccine Industry Chain Analysis
12.2 Swine Parvovirus Disease Vaccine Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Swine Parvovirus Disease Vaccine Production Mode & Process
12.4 Swine Parvovirus Disease Vaccine Sales and Marketing
12.4.1 Swine Parvovirus Disease Vaccine Sales Channels
12.4.2 Swine Parvovirus Disease Vaccine Distributors
12.5 Swine Parvovirus Disease Vaccine Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Swine Parvovirus Disease Vaccine Industry Trends
13.2 Swine Parvovirus Disease Vaccine Market Drivers
13.3 Swine Parvovirus Disease Vaccine Market Challenges
13.4 Swine Parvovirus Disease Vaccine Market Restraints
14 Key Findings in The Global Swine Parvovirus Disease Vaccine Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer